Login

Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Inside the Mind of a Tennis Pro: Rituals, Signature Moves, and 2017 Goals
00:10:00
Paul Idelman - Chief Investment Strategist at Russell Investments
00:00:00
Cogstate Limited - Brad O’Connor Chief Executive Officer, CogState Ltd
00:10:00
Culture of Safety at ARC Resources | Harold Kvisle, Chairman, ARC Resources LtdARX:TOR
00:10:00
Gust Kepler of BlackBoxStocks on the Rise of Retail Investors and Wall Street's David vs Goliath Battle | Gust Kepler, CEO, BlackBoxStocks Inc.
00:00:00
Dr. Mariola Söhngen Chief Executive Officer and Executive Director, Proteome Sciences
00:10:00
Current Market Volatility: Investor Strategies | David Hefty - CHIEF EXECUTIVE OFFICER of Credent Wealth Management
00:10:00
Machine Learning Revolutionizing Pricing in the Corporate Bond Market
00:10:00
Chemring Australia - Microsoft SharePoint and Autodesk Vault Professional | Michael Ord, Group Chief Executive, Chemring Group PLCCHG:LSE
00:10:00
Treatment Decisions With Greater Confidence|Anders Rylander,CEO,Biovica International
00:10:00
Gérard Perrier Industrie operates within the fertilizer production facilities of Azomures S.A., focusing on industrial engineering solutions.
00:10:00
Aurizon Holdings: Australia's Premier Rail Freight Operator | Andrew Harding - CEO of Aurizon

© 2017 - Neuhu+